SCHEMBL5249135

SCHEMBL5249135

COc1ncccc1Nc1nnc(C(=O)Nc2ccccc2)o1

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 20/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3544946 0.82 DGAT1 (0.72) DGAT1
SCHEMBL3544952 0.82 DGAT1 (0.72) DGAT1
SCHEMBL5302841 0.78 DGAT1 (0.56) DGAT1
SCHEMBL5301809 0.78 DGAT1 (0.60) DGAT1
SCHEMBL5252296 0.78 DGAT1 (0.73) DGAT1
SCHEMBL5302124 0.76 DGAT1 (0.71) DGAT1
SCHEMBL5298516 0.76 DGAT1 (0.72) DGAT1
SCHEMBL5248671 0.75 DGAT1 (0.64) DGAT1
SCHEMBL18236237 0.75 DGAT1 (0.55) DGAT1
SCHEMBL31263996 0.74 AURKA (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1833806-A1 OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS AstraZeneca AB (SE) 2007-09-19 EP disclosed
WO-2006064189-A1 OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS ASTRAZENECA AB (SE) 2006-06-22 WO disclosed